Can nitrofurantoin cause postural (orthostatic) hypotension in patients with heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin and Postural Hypotension in Heart Failure Patients

Nitrofurantoin is generally safe to use in patients with heart failure as it does not cause postural hypotension, provided the patient has adequate renal function.

Nitrofurantoin and Cardiovascular Effects

  • Nitrofurantoin is not listed among medications that cause orthostatic hypotension in any of the major cardiovascular guidelines 1
  • Unlike vasodilators (such as nitrates) which are known to cause significant drops in blood pressure and postural hypotension, nitrofurantoin does not have vasodilatory properties 1
  • Nitrofurantoin is an antibiotic that works through inhibition of bacterial enzymes and does not have direct cardiovascular effects that would cause orthostatic hypotension 2

Heart Failure Considerations

  • The primary medications that cause orthostatic hypotension in heart failure patients are vasodilators (nitrates, hydralazine), diuretics, ACE inhibitors, ARBs, and certain calcium channel blockers 1
  • Heart failure patients are already predisposed to orthostatic hypotension due to their underlying condition, with prevalence ranging from 8% in community-living individuals to 83% in hospitalized elderly patients 2
  • When prescribing for heart failure patients, the main drugs to avoid or use with caution due to orthostatic hypotension risk include:
    • Nitrates (nitroglycerin, isosorbide) 1, 3
    • Calcium channel blockers, particularly immediate-release nifedipine 1
    • Alpha-blockers 1
    • Central-acting antihypertensives (clonidine, moxonidine) 1

Important Considerations When Using Nitrofurantoin

  • Nitrofurantoin should be used with caution in patients with renal impairment, which is common in heart failure patients 1
  • The primary contraindication for nitrofurantoin in heart failure patients would be impaired renal function (creatinine clearance <30 mL/min) rather than concern for orthostatic hypotension 1
  • Heart failure patients often take multiple medications that may interact with each other, so a thorough medication review is important when adding any new medication 4

Monitoring Recommendations

  • While nitrofurantoin itself doesn't cause orthostatic hypotension, heart failure patients should still be monitored for:
    • Worsening heart failure symptoms 1
    • Renal function, as nitrofurantoin is contraindicated in significant renal impairment 1
    • Potential drug interactions with other heart failure medications 4

Alternatives if Concerns Exist

  • If there are specific concerns about a patient's cardiovascular stability, alternative antibiotics without any hemodynamic effects could be considered 2, 5
  • For patients with severe heart failure and compromised renal function, consultation with both cardiology and infectious disease specialists may be warranted to select the most appropriate antimicrobial therapy 2

In conclusion, nitrofurantoin does not cause postural hypotension and can be safely administered to heart failure patients who have adequate renal function. The primary concern with nitrofurantoin in heart failure patients is not orthostatic hypotension but rather the potential for reduced drug clearance in patients with concomitant renal impairment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Heart failure and orthostatic hypotension.

Heart failure reviews, 2016

Guideline

Nitroglycerin-Related Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Drug Interactions and Management in Patients with Multiple Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.